相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。An efficient synthesis of new caffeine-based chalcones, pyrazolines and pyrazolo[3,4-b][1,4]diazepines as potential antimalarial, antitrypanosomal and antileishmanial agents
Braulio Insuasty et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Synthesis, leishmanicidal, trypanocidal and cytotoxic activity of quinoline-hydrazone hybrids
Juan Carlos Coa et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Reactivity of δ-substituted α,β-unsaturated cyclic lactones with antileishmanial activity
Wilson Cardona et al.
MOLECULAR SIMULATION (2014)
Synthesis, Leishmanicidal and Cytotoxic Activity of Triclosan-Chalcone, Triclosan-Chromone and Triclosan-Coumarin Hybrids
Elver Otero et al.
MOLECULES (2014)
Control of malaria and other vector-borne protozoan diseases in the tropics: enduring challenges despite considerable progress and achievements
Denis Zofou et al.
INFECTIOUS DISEASES OF POVERTY (2014)
Multifunctional tacrine flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease
Su-Yi Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
SYNTHESIS AND LEISHMANICIDAL ACTIVITY OF NEW BIS-ALKYLQUINOLINES
WILSON CARDONA et al.
JOURNAL OF THE CHILEAN CHEMICAL SOCIETY (2013)
Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs
Sergio A. Pulido et al.
ACTA TROPICA (2012)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
In Vitro and In Vivo Studies of the Utility of Dimethyl and Diethyl Carbaporphyrin Ketals in Treatment of Cutaneous Leishmaniasis
Viviana M. Taylor et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Protective Therapy with Novel Chromone Derivative against Leishmania donovani Infection Induces Th1 Response in vivo
Suvadip Mallick et al.
CHEMOTHERAPY (2011)
Leishmaniasis impact and treatment access
M. den Boer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Phase transfer catalyzed synthesis of bis-quinolines: Antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation
Partha Palit et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Biological Activities of Quinoline Derivatives
Suresh Kumar et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials
Nashira Campos Vieira et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Synthesis of chalcone analogues with increased antileishmanial activity
P Boeck et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases
H Nakayama et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Synthesis and antileishmanial activities of novel 3-substituted quinolines
AG Tempone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Silica sulfuric acid as an efficient and reusable reagent for crossed-aldol condensation of ketones with aromatic aldehydes under solvent-free conditions
P Salehi et al.
JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY (2004)
Cysteine peptidases as virulence factors of Leishmania
JC Mottram et al.
CURRENT OPINION IN MICROBIOLOGY (2004)
Biological evaluation of substituted quinolines
X Franck et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Synthesis and biological evaluation of substituted quinolines:: Potential treatment of protozoal and retroviral co-infections
MA Fakhfakh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Structure-activity relationships of antileishmanial and antimalarial chalcones
M Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues
M Hadjeri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The combinatorial synthesis of bicyclic privileged structures or privileged substructures
DA Horton et al.
CHEMICAL REVIEWS (2003)
Combined microwave and ultrasound assisted Williamson ether synthesis in the absence of phase-transfer catalysts
YQ Peng et al.
GREEN CHEMISTRY (2002)
Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi
R Dietze et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2001)
Inhibition of fumarate reductase in Leishmania major and L-donovani by chalcones
M Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
In vitro leishmanicidal activity of naturally occurring chalcones
O Kayser et al.
PHYTOTHERAPY RESEARCH (2001)